Tamoxifen: Are Jacksonville docs moving from 5 to 10-year doses?
Some women don't have a bit of trouble taking Tamoxifen, the well-known cancer drug for estrogen positive receptor breast cancer. Others, though, hate Tamoxifen.
At least they hate the side effects. Who can blame them? Nobody wants to be sitting at a meeting and go from freezing cold to dripping sweat in two minutes.
But Jacksonville doctors are moving some of the patients now to 10 years of the drug from the typical five years.
To be clear, the decision is made on a case-by-case basis. It's not appropriate for everyone.
The move comes from findings announced in the Atlas study in December. Since then, doctors have had time to absorb the findings and decide which patients they'd like to change to a 10-year-plan.
More on First Coast News